Metabolism of dihydroergotamine by a cytochrome P-450 similar to that involved in the metabolism of macrolide antibiotics

References

• Aellig W. Investigation of the venoconstriction effect of 8′hydroxy-dihydroergotamine. The main metabolite of dihydroergotamine. European Journal of Clinical Pharmacology 1984; 26: 239–242
   PubMedGoogle Scholar
• Black S. D., Coon M. J. Comparative structures of P-450 cytochromes. Cytochrome P-450, P. R. Ortiz de Montellano. Plenum, New York 1986; 161–216
   Google Scholar
• Bonfils C., Dalet-Beluche I., Maurel P. Induction by triacetyloleandomycin and partial purification of a LM3 form of cytochrome P-450 from rabbit liver microsomes. Biochemical and Biophysical Research Communications 1982; 104: 1011–1017
   PubMedGoogle Scholar
• Collignon F., Pradelles P. Highly sensitive and specific radioimmunoassays for dihydroergotoxine components in plasma. European Journal of Nuclear Medicine 1984; 9: 23–27
   PubMedGoogle Scholar
• Delaforge M., Jaouen M., Mansuy D. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite complexes: a structure-activity relationship. Biochemical Pharmacology 1983; 32: 2309–2318
   PubMed Web of Science ®Google Scholar
• Delaforge M., Jaouen M., Mansuy D. The cytochrome P-450 metabolite complex derived from troleandomycin: properties in vitro and stability in vivo. Chemico-Biological Interaction 1984; 51: 371–376
   PubMedGoogle Scholar
• Dumont M., Decouet G., Lebigot J. F., Erlinger S. Mechanism of uptake of dihydroergotamine by isolated rat hepatocytes: effect of troleandomycin. Biochemical Pharmacology 1985; 234: 239–243
   Google Scholar
• Gonzalez F. J., Nebert D. W., Hardwich J. P., Kasper C. B. Complete cDNA and protein sequence of a pregnenolone 16 alpha-carbonitrile-induced cytochrome P-450. A representative of a new gene family. Journal of Biological Chemistry 1985; 260: 7435–7441
   PubMed Web of Science ®Google Scholar
• Grognet J. M., Doignon J. L., Riviére R., Brunengo J. F., Delaforge M., Istin M. Two immunoassays for studying pharmacokinetics and metabolism of dihydroergotamine. Proceedings of the Third European Congress of Biopharmaceutics and Pharmacokinetics. Freiburg 1987; Vol. 1: 293–300
   Google Scholar
• Guengerich F. P., Dannan G. A., Wright S. J., Martin M. T., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes P-450. Electrophoretic, spectral, catalytic and immunochemical properties and inductibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 1982; 21: 6019–6030
   PubMed Web of Science ®Google Scholar
• Halpert J. R. Multiplicity of steroid-inducible cytochrome P-450 in rat liver microsomes. Archives of Biochemistry and Biophysics 1988; 263: 59–68
   PubMed Web of Science ®Google Scholar
• Hostetler K. A., Wrighton S. A., Kremers P., Guzelian P. S. Immunochemical evidence for multiple steroid-inducible hepatic cytochrome P-450 in the rat. Biochemical Journal 1987; 245: 27–33
   PubMed Web of Science ®Google Scholar
• Kremers P., Beaune P., Cresteil T., DeGraeve J., Columelli S., Leroux J. P., Gielen J. Cytochrome P-450 monooxygenase activities in human and rat liver microsomes. European Journal of Biochemistry 1981; 118: 599–606
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Ludden T. M. Pharmacokinetic interactions of the macrolide antibiotics. Clinical Pharmacokinetics 1985; 10: 63–79
   PubMed Web of Science ®Google Scholar
• Mansuy D., Delaforge M., Leprovost E., Flinois J. P., Columelli S., Beaune P. Induction of cytochrome P-450 in rat liver microsomes by the antibiotic troleandomycin: partial purification and properties of cytochrome P-450-troleandomycin metabolite complex. Biochemical and Biophysical Research Communications 1981; 103: 1201–1208
   PubMedGoogle Scholar
• Martinet M., Kiechel J. R. Interaction of dihydroergotamine and triacetyloleandomycin in the minipig. European Journal of Drug Metabolism and Pharmacokinetics 1983; 8: 261–267
   PubMedGoogle Scholar
• Maurer G., Frick W. Elucidation of the structure and receptor binding studies of the major primary metabolite of dihydroergotamine in man. European Journal of Clinical Pharmacology 1984; 26: 463–470
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2379
   PubMed Web of Science ®Google Scholar
• Pershing L. K., Franklin M. R. Cytochrome P-450 metabolic intermediate complex formation and induction by macrolide antibiotics; a new class of agents. Xenobiotica 1982; 12: 687–699
   PubMed Web of Science ®Google Scholar
• Pessayre D., Descatoire V., Konstantinova-Mitcheva M., Wandscheer J. C., Cobert B., Level R., Benhamou J. P., Jaouen M., Mansuy D. Self-induction by triacety-loleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochemical Pharmacology 1981a; 30: 553–558
   PubMed Web of Science ®Google Scholar
• Pessayre D., Konstantinova-Mitcheva M., Descatoire V., Cobert B., Wandscheer J. C., Level R., Feldman G., Mansuy D., Benhamou J. P. Hypoactivity of cytochrome P-450 after triacetyloleandomycin administration. Biochemical Pharmacology 1981b; 30: 559–564
   PubMed Web of Science ®Google Scholar
• Pessayre D., Larrey D., Vitaux J., Breil P., Belghiti J., Benhamou J. P. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in human. Biochemical Pharmacology 1982; 31: 1699–1704
   PubMed Web of Science ®Google Scholar
• Sartori E., Delaforge M., Mansuy D., Beaune P. Some erythromycin derivatives are strong inducers in rats of a cytochrome P-450 very similar to that induced by 16αpregnenolone carbonitrile. Biochemical and Biophysical Research Communications 1985; 128: 1434–1439
   PubMedGoogle Scholar
• Schran H. F., Schwarz H. J., Talbot K. C., Loeffle L. J. Specific radioimmunoassay of ergot peptid alkaloids in plasma. Clinical Chemistry 1979; 25: 1928–1933
   PubMedGoogle Scholar
• Wang P. P., Beaune P., Kaminski L. S., Dannan G. A., Kadlubar F. F., Larrey D., Guengerich F. P. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 1983; 22: 5375–5383
   PubMed Web of Science ®Google Scholar
• Watkins P. B., Wrighton S. A., Maurel P., Schuetz E. G., Mendez-Picon G., Parker G. A., Guzelian P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proceedings of the National Academy of Sciences, USA 1985; 82: 6310–6314
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Maurel P., Schuetz E. G., Watkins P. B., Young B., Guzelian P. S. Identification of the cytochrome P-450. induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450. Biochemistry 1985; 24: 2171–2178
   PubMed Web of Science ®Google Scholar